Navajo Nation prepares for vaccinations as FDA moves closer to Pfizer vaccine approval

On Dec. 10, the U.S. Food and Drug Administration’s advisory committee recommended the authorization of the Pfizer-BioNTech vaccine for COVID-19.On Dec. 10, the U.S. Food and Drug Administration’s advisory committee recommended the authorization of the Pfizer-BioNTech vaccine for COVID-19.